Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373771 · ClinicalTrials.gov registry record · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
A NA study of Sickle Cell Crisis, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 5,328
- Enrollment target
- 1
- Study location
NCT05373771 is a NA study of Sickle Cell Crisis that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 5,328 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05373771, a NA study of Sickle Cell Crisis, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,328 participants
- Enrollment target
- 1
- Study location
Study Summary
Sickle cell disease (SCD) is an inherited blood disorder affecting approximately 36,000 children in the United States, approximately 90% of whom are Black. The disease is characterized by recurrent, severe pain crises which result in high rates of emergency department visits and hospitalizations, and decreased quality of life. The National Heart, Lung and Blood Institute, as well as the American Society of Hematology, have endorsed pain management guidelines regarding the timeliness of care for children presenting with these acute pain crises. These evidence-based guidelines are infrequently followed, resulting in increased pain and hospitalizations. In additional to other barriers to following the guideline, structural racism has been proposed as a significant contributor and the New England Journal of Medicine recently called for the institution of SCD-specific pain management protocols to combat structural racism and reduce time to opioid administration. The investigators' long-term goal is to improve the care and health outcomes of children with acute painful vaso-occlusive crisis treated in the emergency department. The overall aim of the investigators is to test a care pathway using multifaceted implementation strategies to increase guideline adherent care for children in the emergency department with acute painful vaso-occlusive crisis.
Conditions Studied
Interventions
- OTHER Care pathway
Study Locations (1)
Wisconsin
- Children's Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,328 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05373771
The ClinicalTrials.gov registry entry for NCT05373771 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5,328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sickle Cell Crisis appearing as the primary indexed condition, and to 1 intervention - of which Care pathway is the first listed.
NCT05373771 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05373771 about?
NCT05373771 is a clinical study titled "Sickle Cell Improvement: Enhancing Care in the Emergency Department". Sickle cell disease (SCD) is an inherited blood disorder affecting approximately 36,000 children in the United States, approximately 90% of whom are Black. The disease is characterized by recurrent, severe pain crises which result in high rates of emergency department visits and hospitalizations, an...
What is the current status of trial NCT05373771?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,328 participants. The study started on 2021-09-01. Estimated completion is 2027-08-31.
What conditions does trial NCT05373771 study?
This clinical trial studies the following conditions: Sickle Cell Crisis.
What interventions are being tested in trial NCT05373771?
The interventions under investigation include: Care pathway (OTHER).
Who is sponsoring clinical trial NCT05373771?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05373771 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.